Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Navio logo — We’re changing the narrative around cancer

Navio

We’re changing the narrative around cancer

Founded 2018 United States San Francisco, United States 1 employees Series B Total: $25.40M Digital Health, Health Care +1

General Information

Company Name Navio
Founded Year 2018
Location United States San Francisco, United States
Employees 1
Industries Digital Health, Health Care, Information Technology
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Navio. To contact Navio, visit navio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Navio compare?

A PDF of Navio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Navio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Navio

Navio is a United States-based startup founded in 2018. The company's mission is to change the narrative around cancer. It offers healthcare providers early access to treatment timelines that can save time and improve patient experience, while providing a free app for patients and caregivers to manage treatment for malignant brain tumors. In November 2005, Navio secured a significant $25.40M Series B investment from WK Technology Fund and VantagePoint Capital Partners. This investment reflects the confidence of these prominent investors in Navio's potential to make an impact in the Health Care and Information Technology industries. Navio's focus on addressing critical healthcare challenges through technology-driven solutions demonstrates its potential for growth and influence in the industry. The recent investment is expected to propel Navio's efforts in revolutionizing cancer treatment and patient care, showcasing promise for both investors and the healthcare community.

Business keywords: cancer treatment, patient support, brain tumor, clinical trials, healthcare app, treatment management, caregiver support

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $25.40M 2
WK Technology Fund VantagePoint Capital Partners
WK Technology Fund, VantagePoint Capital Partners
08 Nov 2005

Navio Alternatives & Competitors

View All Alternatives
Navio vs
ShadowNurse, Inc.
ShadowNurse, Inc. United States

On a mission to get the people the healthcare they deserve with remote care navigation - powered by...

6 employees
Care Economy, Digital Health
Navio vs
Outcomes4Me
Outcomes4Me United States

On a mission to democratize cancer patient care, one life at a time.

33 employees
Biotechnology, Health Care
Navio vs
MediXSpace
MediXSpace The Netherlands

A cutting-edge platform that brings doctors and patients together in their fight against cancer.

Pre-Seed
1 employees
Digital Health, Health Care
View all alternatives

FAQ About Navio

We’re changing the narrative around cancer
Navio was founded in 2018.
Navio is headquartered in San Francisco, United States.
Navio operates in Digital Health, Health Care and Information Technology. Its work centres on cancer treatment, patient support, brain tumor and clinical trials.
Navio has approximately 1 employees.
Navio has completed 1 funding round, raising a total of $25.40M. The latest funding stage is Series B.
Top alternatives and competitors to Navio include ShadowNurse, Inc., Outcomes4Me, MediXSpace, Fuse Oncology, Inc., Qure4u. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Navio and ShadowNurse, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Navio, https://bouncewatch.com/company/navio, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes